Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study
PLOS One · 2025
DOI: 10.1371/journal.pone.0333405 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von MohammedBashar Al-Qazzan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Antioxidants, Anti-Inflammatory Agents, Lactoylglutathione Lyase, Chelating Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Glyoxalase I is a crucial target in cancer treatment due to its involvement in detoxifying methylglyoxal. Suppressing the activity of Glyoxalase I has great potential for disrupting the pathways that allow cancer cells to survive, creating a new route for cancer treatment. Methodology This study aims to investigate several substances as inhibitors of glyoxalase-I. After demonstrating their efficacy, additional inquiry will concentrate on assessing their cytotoxic and anti-inflammatory capabilities, yielding significant insights for prospective medicinal uses. The selection of these chemicals as potential Glyoxalase I inhibitors was based on their ability to bind metals, in crucial enzymes. These compounds consist of catechol, dihydroxy, trihydroxy benzene, and functional groups such hydroxamic acid, sulfur, carboxylic acid, amide, and 3-hydroxy-4-pyridone with the aim to suppress Glyoxalase I in vitro . Docking protocol was employed to examine the binding interactions with the active site. These auspicious compounds have been subjected to cytotoxicity assay testing employing Sulforhodamine B in eleven distinct cell lines, as well as anti-inflammatory and antioxidant evaluations.
Results
Glyoxalase I inhibition revealed that 4-hydroxy-estradiol exhibited the highest efficacy with an IC 50 value of 0.226 µM. Trichostatin A demonstrated a significant anti-proliferation effect in colorectal cancer cells (CACO2, HCT116, SW620, HT29) with IC 50 values ranging from 14.0 µM to 27.0 µM. Furthermore, it exhibited substantial decreases in viability, ranging from 1.4 µM to 14.7 µM, in cancer cell cultures of skin (A375), lung (A549), prostate (PC3), breast (MCF7 and T47D), and cervical (HeLa). Except for 4-hydroxyestrdiol, the other phytochemicals demonstrated considerable selectivity in reducing the viability of cancer cells in monolayers of colorectal, cervical, mammary, lung, and skin tissues. In comparison to indomethacin and vitamin C, all of the studied natural compounds exhibited excellent anti-inflammatory properties in LPS-primed RAW 264.7 murine macrophages and had moderate antioxidant abilities comparable to ascorbic acid, with IC 50 values from 26.0 µM to 99.0 µM.
Conclusion
Further assessment of molecular action mechanisms and structural betterments/enhancements and/or derivatization of promising potent agents with antiglyoxylase – antiinflammation duality along with differential cytotoxicity and reductive capacities are advisably warranted with appropriately matched downstream in vivo validation modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- College of Pharmacy, University of Bilad Alrafidain, Diyala, Iraq.
- Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science & Technology, Irbid, Jordan.
- School of Pharmacy, University of Jordan, Amman, Jordan.
- College of Pharmacy, The University of Mashreq, Baghdad, Iraq.
ORCID-Profile: MohammedBashar Al-Qazzan, Aref Zayed, Mohammed Al-Akeedi
Zitieren
APA
Al-Qazzan, M., Al-Balas, Q., Alnajjar, B., Kasabri, V., Al-Hiari, Y., Zayed, A., AlKhateeb, R., & Al-Akeedi, M. (2025). Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study. PLOS One. https://doi.org/10.1371/journal.pone.0333405
Vancouver
Al-Qazzan M, Al-Balas Q, Alnajjar B, Kasabri V, Al-Hiari Y, Zayed A, et al. Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study. PLOS One. 2025. doi:10.1371/journal.pone.0333405
BibTeX
@article{AlQazzan2025,
author = {Al-Qazzan, MohammedBashar and Al-Balas, Qosay and Alnajjar, Belal and Kasabri, Violet and Al-Hiari, Yusuf and Zayed, Aref and AlKhateeb, Rema and Al-Akeedi, Mohammed},
title = {Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333405}
}
EUVIMED